RWD Study in HER2+ mBC Patients in Third-Line Therapy
NCT04566458
·
clinicaltrials.gov ↗
COMPLETED
Status
63
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Stage IV
Interventions
OTHER:
No intervention
Sponsor
Exactis Innovation
Collaborators
[object Object]